Seagull eyes viewer
Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Nanocap Pearl Gull Iron (ASX:PLG) has blamed low rare earths prices on international commodity markets in announcing its decision not to acquire Huemul.

In June this year, the company identified geological particulars at Huemul’s acreage that it said were similar to Chinese REE deposits. It had been hoping to farm-into the play.

Huemul itself, in June, was seeking to acquire up to 80% in a Chilean company that actually owned the permit rights in question across five tenements.

But the company confirmed on Monday that deal is no more. The culprit, according to Pearl Gull, is continued weakness in rare earths prices.

“Due to current market sentiment and headwinds in the market price for Rare Earth Elements, the Company considers it no longer in its best interests to farm-in to the La Marigen Rare Earths Project in Chile,” the company wrote.

“The proposed appointment of Dr John Mair to the Pearl Gull Board, pursuant to the Acquisition, will also not occur.”

Pearl Gull said it will continue to progress its operations at Cockatoo Island.

PLG last traded at 1.3cps.

PLG by the numbers
More From The Market Online
The Market Online Video

ASX Market Close: Bourse finishes week on a high as Wisetech pummeled | November 22, 2024

The ASX200 closed up 0.85% at 8,393 points. Economists increasingly expect interest rates in Australia won’t…
The Market Online Video

HotCopper Highlights: Your most watched stocks for Week 47, 2024

In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing,…
Nuclear explosion mushroom cloud concept

Week 47 Wrap: HotCopper users’ most watched; Brent lifts on Putin’s scary letter; RFK dents CSL

Welcome to the end of another week. Let's start with what HotCopper users have been watching…
Dale Gillham's photo, and wording 'Words from Wealth Within's Chief Analyst Dale Gillham.

Dale Gillham’s weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in th…